Health Tech Capitol | BioTechnique Begins Phase 2 of Partnership
15629
post-template-default,single,single-post,postid-15629,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

BioTechnique Begins Phase 2 of Partnership

26 Aug BioTechnique Begins Phase 2 of Partnership

Posted at 15:16h in Uncategorized by
0 Likes

BioTechnique, a specialty drug aseptic fill-finish contract manufacturing organization, will launch a second phase of manufacturing in partnership with a major, international not-for-profit organization, the company announced recently.

“We are very pleased to support a major non-profit trust in bringing their novel dosage form to market,” BioTechnique CEO John Clapham said in a statement. “With the continuation of this live attenuated virus manufacturing partnership, we have broadened our ability meet demand from our customers who need a reliable contract manufacturing partner.”

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.